A phase I study of gemcitabine, capecitabine, and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

被引：0
|
作者：
Nallapareddy, S.
Eckhardt, S. G.
O'Bryant, C. L.
Eppers, S.
Diab, S.
Kane, M. A.
Weekes, C. D.
Spratlin, J. L.
Messersmith, W. A.
Leong, S.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies
    Haigentz, M
    Kim, M
    Sorich, J
    Lee, J
    Hochster, H
    Macapinlac, M
    Mirchandani, D
    Sewak, S
    Pavlick, A
    Volm, M
    Hamilton, A
    Muggia, FM
    ANTI-CANCER DRUGS, 2003, 14 (04) : 321 - 326
  • [32] Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies
    Mahadevan, Daruka
    Dreisbach, Luke
    Kristedja, Timothy
    Williams, Debbie
    Obregon, Yrma
    Kurtin, Sandy
    Von Hoff, Daniel D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (06): : 607 - 611
  • [33] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Lia Gore
    E. Rivera
    M. Basche
    S. L. Moulder-Thompson
    J. Li
    S. Eppers
    S. Grolnic
    C. O’Bryant
    D. Cleere
    Y. A. Elsayed
    S. G. Eckhardt
    Investigational New Drugs, 2012, 30 : 1942 - 1949
  • [34] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [35] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
  • [36] A phase I study of gemcitabine and docetaxel for advanced stage solid tumors
    Poole, ME
    Bernard, SA
    Churchel, MA
    Weissler, MC
    Calvo, B
    Cance, W
    Ollila, D
    Koruda, M
    Behrns, K
    Detterbeck, FC
    CANCER INVESTIGATION, 2003, 21 (03) : 350 - 354
  • [37] Phase I study of vandetinib in combination with gemcitabine and oxaliplatin in advanced solid malignancies
    Wang, Peng
    Owonikoko, Taofeek Kunle
    Lin, Yan
    Stoller, Ronald G.
    Petro, Daniel P.
    Park, Deric M.
    Ramanathan, Ramesh K.
    Chu, Edward
    Beumer, Jan Hendrik
    Appleman, Leonard Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
    Deenen, Maarten J.
    Klumpen, Heinz-Josef
    Richel, Dick J.
    Sparidans, Rolf W.
    Weterman, Mariette J.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Wilmink, Johanna W.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1557 - 1565
  • [39] Phase I study of TAS-114 in combination with capecitabine in patients with advanced solid tumors
    LoRusso, Patricia M.
    Miller, Kathy D.
    Shields, Anthony F.
    Chung, Ki Y.
    Yoshisue, Kunihiro
    Aoyama, Takekazu
    Lenz, Heinz-Josef
    CANCER RESEARCH, 2018, 78 (13)
  • [40] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345